#molecule

Collection of molecule news, found 49 news.

Asia Pacific Needs to Scale Low-Carbon Technologies Rapidly to Reduce Carbon Emissions: Black & Veatch

- Asia Pacific must rapidly identify and adopt the next generation of low-carbon and scalable infrastructure to ...

AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site

 AbbVie (NYSE: ABBV) strengthened its manufacturing capabilities by breaking ground Thursday on a new US$223 ...

Ascletis Announces Dosing of the First Patient in Phase III Clinical Trial of ASC40 (Denifanstat) for Treatment of Acne

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces dosing of the first patient in Phase III clinical trial ...

Indonesia contributing greatly to astronomy development: BRIN

Indonesia, on account of its strategic location, has been enabling astronomers to make observations of celestial ...

Allorion Therapeutics Announces Exclusive Option and Global License Agreement

Allorion Therapeutics ("Allorion"), a US and China-based biotechnology company that focuses on the discovery of ...

Accelerated Liquefied Natural Gas Production Essential for Transitioning to a Low-Carbon Future: Black & Veatch

The urgency to increase liquefied natural gas (LNG) production and improve the security of supply will be central ...

HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations

HighTide Therapeutics Inc. ("HighTide"), a globally integrated clinical-stage biopharmaceutical company developing ...

BRIN seeks to advance biodiversity research using cryo-EM

The National Research and Innovation Agency (BRIN) will seek to further biodiversity research on a molecular level by ...

LintonPharm to release data on Catumaxomab for advanced Gastric Cancer with peritoneal metastasis at 2022 ASCO Annual Meeting

LintonPharm Co., Ltd., a China-based biopharmaceutical company focusing on the development of T cell engaging ...

EIG and Fluxys partner in key LNG infrastructure supporting decarbonization in Chile

EIG, a leading institutional investor to the global energy and infrastructure sectors, and Fluxys, a leading energy ...

LintonPharm announces first patient dosed in Phase 1 clinical trial of catumaxomab for Non-Muscle-Invasive Bladder Cancer unresponsive to Bacillus Calmette-Guerin

LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell ...

Milliken & Company publishes third annual corporate sustainability report

Global manufacturer Milliken & Company today released its third annual corporate sustainability report, entitled ...

LintonPharm announces authorization from China health authority (NMPA) to proceed with a phase 1/2 trial evaluating catumaxomab for the treatment of Non-Muscle Invasive Bladder Cancer

LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell ...

Milliken & Company appoints Cindy Boiter as executive vice president, Chemical Division president

Milliken & Company is pleased to announce Cindy Boiter has been promoted to executive vice president and president ...

Aptorum Group announces submission of Clinical Trial Application

Regulatory News:     Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum ...